Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $240.32 million. The enterprise value is $130.68 million.

Market Cap	240.32M
Enterprise Value	130.68M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TENX has 39.69 million shares outstanding. The number of shares has increased by 4,500.28% in one year.

Current Share Class	4.15M
Shares Outstanding	39.69M
Shares Change (YoY)	+4,500.28%
Shares Change (QoQ)	+3.66%
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	10.41%
Float	4.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.19
P/TBV Ratio	2.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 40.48

Current Ratio	40.48
Quick Ratio	40.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,794.87

Financial Efficiency

Return on equity (ROE) is -39.78% and return on invested capital (ROIC) is -27.55%.

Return on Equity (ROE)	-39.78%
Return on Assets (ROA)	-26.60%
Return on Invested Capital (ROIC)	-27.55%
Return on Capital Employed (ROCE)	-24.63%
Revenue Per Employee	n/a
Profits Per Employee	-$4.04M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.79% in the last 52 weeks. The beta is 1.91, so TENX's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	+73.79%
50-Day Moving Average	5.86
200-Day Moving Average	5.30
Relative Strength Index (RSI)	58.53
Average Volume (20 Days)	11,113

Short Selling Information

The latest short interest is 308,330, so 0.78% of the outstanding shares have been sold short.

Short Interest	308,330
Short Previous Month	336,098
Short % of Shares Out	0.78%
Short % of Float	7.53%
Short Ratio (days to cover)	18.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.92M
Pretax Income	-10.10M
Net Income	-24.21M
EBITDA	n/a
EBIT	-26.92M
Earnings Per Share (EPS)	-$1.00

Full Income Statement

Balance Sheet

The company has $111.45 million in cash and n/a in debt, giving a net cash position of $111.45 million or $2.81 per share.

Cash & Cash Equivalents	111.45M
Total Debt	n/a
Net Cash	111.45M
Net Cash Per Share	$2.81
Equity (Book Value)	109.29M
Book Value Per Share	2.77
Working Capital	109.29M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-16.61M
Capital Expenditures	n/a
Free Cash Flow	-16.61M
FCF Per Share	-$0.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,500.28%
Shareholder Yield	-4,500.28%
Earnings Yield	-10.00%
FCF Yield	-6.86%

Analyst Forecast

The average price target for TENX is $16.00, which is 164.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	164.27%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	0.0125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2